Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2003-08-11
2011-11-29
Graser, Jennifer (Department: 1645)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S185100, C424S190100, C424S234100, C435S069100, C435S069300, C435S071100, C530S300000, C530S350000, C536S023700
Reexamination Certificate
active
08067004
ABSTRACT:
The invention provides a novel surface polypeptide fromNeisseria meningitidisas well as nucleic acid and nucleic acid sequence homologues encoding this protein. Pharmaceutical compositions containing the polypeptide and nucleic acids of the invention are also disclosed as well as methods useful in the treatment, prevention and diagnosis ofN. meningitidisinfection.
REFERENCES:
patent: 4702911 (1987-10-01), McMichael
patent: 4769240 (1988-09-01), Brinton
patent: 5618541 (1997-04-01), Quentin-Millet
patent: 5646259 (1997-07-01), St. Geme, III et al.
patent: 6197312 (2001-03-01), Peak
patent: 6495345 (2002-12-01), Peak
patent: 6607729 (2003-08-01), Peak
patent: 6709660 (2004-03-01), Scarlato
patent: 6780419 (2004-08-01), Ruelle
patent: 2009/0270591 (2009-10-01), Peak et al.
patent: 2010/0331537 (2010-12-01), Peak et al.
patent: 0 301 992 (1989-02-01), None
patent: WO 92/03467 (1992-03-01), None
patent: WO 93/06861 (1993-04-01), None
patent: WO 96/29412 (1996-09-01), None
patent: WO 97/26359 (1997-07-01), None
patent: WO 99/31132 (1999-06-01), None
patent: WO 99/58683 (1999-11-01), None
Sacchi et al., “Considerations on the Use ofNeisseria meningitidisClass 5 Proteins as Meningococcal BC Vaccine Components”,Vaccine, 1995, vol. 13, No. 1, pp. 112-118, Elsevier Science Ltd.
Feng et al., J. Mol. Evol. 25:351-360 (1987).
Higgins et al., Cabios Communications 5(2): 151-153 (1989) .
Hopp et al., Molecular Immunology 20(4): 483-489 (1983).
Kolaskar et al., FEBS 276(1,2): 172-174 (1990).
Welling et al., FEBS 188(2): 215-218 (1985).
Rudinger et al., in “Peptide Hormones,” edited by Parsons, J.A., University Park Press, Jun. 1976, p. 6.
Burgess et al., The Journal of Cell Biology, 111:2129-2138, 1990.
Lazar et al., Molecular and Cellular Biology, 8(3):1247-1252, 1988.
Jobling et al., Mol. Microbiol. 1991, 5(7): 1755-67.
St. Geme et al., Characterization of the Genetic Locus EncodingHaemophilusInfluence Type B Surface Fibrils, J. Bacteriol., Nov. 1996, pp. 6281-6287, vol. 178, No. 21.
Stephen J. Barenkamp and Joseph W. St. Geme III, “Identification of a Second Family of High-molecular-Weight Adhesion Proteins Expressed by Non-TypableHaemophilus Influenzae,” Molecular Microbiology, 1996, 19(6), pp. 1215-1223.
Ruelle, File History of U.S. App. No. 90/007,989, filed Mar. 31, 2006.
Pizza et al. Science 287 (5459): 1816-1820 (2000).
Rosenqvist et al., Infection and Immun. 63(12): 4642-4652 (1995).
Van Der Ley et al., Infection and Immun. 60(8): 3156-3163 (1992).
The American Heritage Dictionary, Second College Edition, p. 680 (1982).
Jennings Michael Paul
Moxon E. Richard
Peak Ian Richard Anseim
Graser Jennifer
Perkins Coie LLP
The University of Queensland
LandOfFree
Surface antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Surface antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Surface antigen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4286406